Compare STRT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRT | LAB |
|---|---|---|
| Founded | 1908 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 345.3M | 347.5M |
| IPO Year | 1996 | 2008 |
| Metric | STRT | LAB |
|---|---|---|
| Price | $78.36 | $0.91 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $93.00 | $1.35 |
| AVG Volume (30 Days) | 78.5K | ★ 6.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.53 | ★ 61.54 |
| EPS | ★ 4.04 | 0.33 |
| Revenue | ★ $439,195,000.00 | $101,937,000.00 |
| Revenue This Year | $4.22 | N/A |
| Revenue Next Year | $2.04 | $2.63 |
| P/E Ratio | $19.27 | ★ $2.77 |
| Revenue Growth | ★ 5.24 | N/A |
| 52 Week Low | $57.01 | $0.70 |
| 52 Week High | $92.50 | $1.72 |
| Indicator | STRT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 52.79 |
| Support Level | $77.01 | $0.90 |
| Resistance Level | $84.20 | $1.02 |
| Average True Range (ATR) | 3.42 | 0.07 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 9.83 | 92.80 |
Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.